What is Gyre Therapeutics, Inc.'s net change in cash?

Gyre Therapeutics, Inc. (GYRE) reported net change in cash of $431K in Q1 2026.

How has Gyre Therapeutics, Inc.'s net change in cash changed year-over-year?

Gyre Therapeutics, Inc.'s net change in cash decreased by 86.7% year-over-year, from $3.23M to $431K.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Gyre Therapeutics, Inc. GYRE Net Change in Cash

Net Change in Cash at other companies

Eli LillyLLY

-$1.99B-1,035%

Madrigal Pharmaceuticals, Inc.MDGL

$28.41M-66.0%

Viking TherapeuticsVKTX

-$47.71M-524%

Theravance BiopharmaTBPH

$120.3M+65.2%

Rigel PharmaceuticalsRIGL

-$16.17M-47.5%

Zevra Therapeutics, Inc.ZVRA

$33.19M+834%

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s net change in cash?: Gyre Therapeutics, Inc. (GYRE) reported net change in cash of $431K in Q1 2026.
How has Gyre Therapeutics, Inc.'s net change in cash changed year-over-year?: Gyre Therapeutics, Inc.'s net change in cash decreased by 86.7% year-over-year, from $3.23M to $431K.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.